Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014808
Filing Date
2020-08-06
Accepted
2020-08-06 07:23:23
Documents
64
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1185797
2 ex10-1.htm EX-10.1 99812
3 ex31-1.htm EX-31.1 16747
4 ex31-2.htm EX-31.2 16810
5 ex32-1.htm EX-32.1 6158
6 ex32-2.htm EX-32.2 6181
  Complete submission text file 0001493152-20-014808.txt   5110010

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE prvb-20200630.xsd EX-101.SCH 36784
8 XBRL CALCULATION FILE prvb-20200630_cal.xml EX-101.CAL 35610
9 XBRL DEFINITION FILE prvb-20200630_def.xml EX-101.DEF 136115
10 XBRL LABEL FILE prvb-20200630_lab.xml EX-101.LAB 289739
11 XBRL PRESENTATION FILE prvb-20200630_pre.xml EX-101.PRE 232286
12 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 832292
Mailing Address P.O. BOX 666 OLDWICK NJ 08858
Business Address P.O. BOX 666 OLDWICK NJ 08858 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 201079813
SIC: 2834 Pharmaceutical Preparations